Product
OPDC-34712
1 clinical trial
1 indication
Indication
ADHDClinical trial
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adult Attention Deficit/ Hyperactivity DisorderStatus: Completed, Estimated PCD: 2011-06-20